$CING - Cingulate ADHD 1 Dose Medicine, MICRO FLOAT, ROCKET SHIP937K shares, 2.2M marketcap micro float. ADHD 1 dose medicine advancing through trials with FDA guidance. I wouldn't be surprised to see NASDAQ:ARCT , NASDAQ:DRRX , or NASDAQ:NLSP buy them up! Do your own due diligence. Do not take this as financial advice. I own shares in this company.
ADHD
$CING - LOW FLOAT + CAP - 1 Pill for ADHD/ANXIETY (ROCKETSHIP?)They announced positive top line results from their P3 trial. Adolescent and paediatric trials are happening both this month and next. Major competitors such as NYSE:JNJ , NYSE:PFE , NYSE:NVS that require multiple pills a day for the same effect. Extremely large TAM. Buyout candidate? We have popped off of the bottom channel and are looking for 1.10. A breakout above that sends it to 1.40-1.50 range. This is my own opinion and shouldn't be taken as financial advice. Own your trades.
$CING - Low Float - Positive Top Line Results - ADHD 1 PILLWe are traveling the bottom of the channel. I think it starts to move up shortly. Adolescent and Pediatric fixed dose phase 3 trials start this month and next month. FDA approval submission early/mid next year. Billion-dollar drug if it can get some funding? This is my own opinion, and you should not take any of this as financial advice.
KMPH Kempharm targets after the volume spikeTarget 1: $29
Target 2: $45
Target 3: $80
If you are interested to test some amazing BUY and SELL INDICATORS which give the signal at the beginning of the candle, not at the end of it, just leave me a message.